Provisional FDA OK For Ranbaxy's Nexium Knockoff (Forbes)
Generic version of the heartburn/acid reflux drug receives tentative approval, allowing it exclusive marketing for 180 days; patent holder AstraZeneca warns of lawsuit.

FDA Will Not Submit Proposal To Congress To Seek Authority To Approve Generic Biotechnology Medications (Medical News Today)
FDA spokesperson Christopher Kelly on Tuesday said that, despite comments from an agency official on Monday, the agency will not submit to Congress a legislative proposal to seek authority to approve generic versions of biotechnology medications, CongressDaily reports (Edney, CongressDaily, 2/6).